Company

ImpediMed Limited

Headquarters: Pinkenba, QLD, Australia

Employees: 73

CEO: Mr. Richard Carreon

ASX: IPD +1.89%

Market Cap

A$145.8 Million

AUD as of July 1, 2024

US$97.1 Million

Market Cap History

ImpediMed Limited market capitalization over time

Evolution of ImpediMed Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ImpediMed Limited

Detailed Description

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

ImpediMed Limited has the following listings and related stock indices.


Stock: ASX: IPD wb_incandescent

Stock: OTC: IPDQF wb_incandescent

Details

Headquarters:

50 Parker Court

Unit 1

Pinkenba, QLD 4008

Australia

Phone: 61 7 3860 3700

Fax: 61 7 3260 1225